These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28745315)

  • 21. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.
    Sun F; Wu K; Yao Z; Mu X; Zheng Z; Sun M; Wang Y; Liu Z; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(12):11500-11516. PubMed ID: 32554858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
    Guan H; You Z; Wang C; Fang F; Peng R; Mao L; Xu B; Chen M
    Cancer Med; 2019 Apr; 8(4):1474-1485. PubMed ID: 30784214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
    Feng S; Sun H; Zhu W
    Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
    Jeong JH; Park SJ; Dickinson SI; Luo JL
    Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases.
    Hussein NA; Ebid SA; Ahmad MA; Khedr GE; Saad DM
    Sci Rep; 2024 Apr; 14(1):8246. PubMed ID: 38589525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
    Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
    FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
    Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
    Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
    Zennami K; Choi SM; Liao R; Li Y; Dinalankara W; Marchionni L; Rafiqi FH; Kurozumi A; Hatano K; Lupold SE
    Mol Cancer Res; 2019 Feb; 17(2):618-627. PubMed ID: 30518628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
    Wan X; Pu H; Huang W; Yang S; Zhang Y; Kong Z; Yang Z; Zhao P; Li A; Li T; Li Y
    Oncotarget; 2016 Aug; 7(32):51284-51300. PubMed ID: 27323416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
    Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
    Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
    J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CMTM5 influences Hippo/YAP axis to promote ferroptosis in glioma through regulating WWP2-mediated LATS2 ubiquitination.
    Fan Y; Zou HQ
    Kaohsiung J Med Sci; 2024 Oct; 40(10):890-902. PubMed ID: 39166861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.
    Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N
    Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA‑93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionω.
    Ma C; Peng P; Zhou Y; Liu T; Wang L; Lu C
    Mol Med Rep; 2020 Jul; 22(1):483-493. PubMed ID: 32319642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.
    Mu H; Xiang L; Li S; Rao D; Wang S; Yu K
    J Cell Biochem; 2019 Apr; 120(4):4987-4997. PubMed ID: 30302800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.
    Ma B; Chen Y; Chen L; Cheng H; Mu C; Li J; Gao R; Zhou C; Cao L; Liu J; Zhu Y; Chen Q; Wu S
    Nat Cell Biol; 2015 Jan; 17(1):95-103. PubMed ID: 25438054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.
    Paramasivam M; Sarkeshik A; Yates JR; Fernandes MJ; McCollum D
    Mol Biol Cell; 2011 Oct; 22(19):3725-33. PubMed ID: 21832154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.
    Chen X; Li Q; Liu X; Liu C; Liu R; Rycaj K; Zhang D; Liu B; Jeter C; Calhoun-Davis T; Lin K; Lu Y; Chao HP; Shen J; Tang DG
    Clin Cancer Res; 2016 Sep; 22(17):4505-16. PubMed ID: 27060154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.